Skip to main content

stock

ELAN · Elanco Animal Health Inc

What Elanco Animal Health Inc reports to the SEC, read from its filings.

Open in the app

Price

The live ELAN price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ELAN.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
499,621,830 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
55.4%
Operating
—
Net
-4.0%

Returns

ROE
-3.0%
ROA
-1.5%

Health

Current ratio
2.1x
Debt/equity
0.6x

Deep value

NCAV
-$3.18B
NCAV per share
-$6.36
Price/NCAV
Locked
NNWC
-$4.75B
NNWC per share
-$9.51
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating income (not reported by this company)Net incomeFiling
2026-06-30$1.37B$798.00M—Operating income: unreported by this company.$54.00M
10-Q filed 2026-08-05
2026-03-31$1.37B$785.00M—Operating income: unreported by this company.$57.00M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$1.14B$589.00M—Operating income: unreported by this company.-$276.00M
DEF 14A filed 2026-04-08
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$1.14B$607.00M—Operating income: unreported by this company.-$34.00M
10-Q filed 2025-11-05
2025-06-30$1.24B$713.00M—Operating income: unreported by this company.$11.00M
10-Q filed 2026-08-05
2025-03-31$1.19B$684.00M—Operating income: unreported by this company.$67.00M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$1.02B$519.00M—Operating income: unreported by this company.-$8.00M
DEF 14A filed 2026-04-08
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$1.03B$538.00M—Operating income: unreported by this company.$364.00M
10-Q filed 2025-11-05
Assets
$13.56B
Equity
$6.59B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$4.71B—-$232.00M$284.00M
2024-12-31$4.44B—$338.00M$394.00M
2023-12-31$4.42B—-$1.23B$131.00M
2022-12-31$4.41B—-$78.00M$281.00M
2021-12-31$4.76B—-$483.00M$324.00M
2020-12-31$3.27B—-$574.00M-$176.00M
2019-12-31$3.07B—$68.00M$84.00M
2018-12-31$3.07B—$86.50M$352.80M
2017-12-31$2.89B—-$310.70M$75.20M
2016-12-31$2.91B—-$47.90M$45.60M

Company filings

events

  • Results

    Results
    Aug 58-K
  • Shareholder vote results

    Shareholder vote results
    May 278-K
  • Results

    Results
    May 68-K
  • Results

    Results
    Feb 248-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jan 128-K
  • Exit or restructuring costs, Regulation FD disclosure

    Exit or restructuring costsRegulation FD disclosure
    12/9/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named ELAN, and the market events around them.

Sign in to see this

Board

The ELAN board could not be loaded.

Retry the ELAN board

nakagai

Signals on ELAN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ELAN board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Elanco Animal Health Inc (ELAN): SEC filings, financials and insider trades · Nakagai